Growing community of inventors

Waltham, MA, United States of America

Mei Su

Average Co-Inventor Count = 7.72

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Mei SuStephanos Ioannidis (3 patents)Mei SuTao Wang (2 patents)Mei SuHai-Jun Zhang (2 patents)Mei SuJames Walter Janetka (1 patent)Mei SuBin Wang (1 patent)Mei SuMichelle Lamb (1 patent)Mei SuPaul D Lyne (1 patent)Mei SuHuiping Guan (1 patent)Mei SuBo Peng (1 patent)Mei SuDingwei Yu (1 patent)Mei SuStephanie K Springer (1 patent)Mei SuAudrey Davies (1 patent)Mei SuThomas Woodrow Gero (1 patent)Mei SuYing Kan (2 patents)Mei SuYing Kang (1 patent)Mei SuXiaomei Feng (1 patent)Mei SuSusan Ashwell (1 patent)Mei SuVibha Oza (1 patent)Mei SuMei Su (3 patents)Stephanos IoannidisStephanos Ioannidis (39 patents)Tao WangTao Wang (9 patents)Hai-Jun ZhangHai-Jun Zhang (2 patents)James Walter JanetkaJames Walter Janetka (31 patents)Bin WangBin Wang (30 patents)Michelle LambMichelle Lamb (13 patents)Paul D LynePaul D Lyne (11 patents)Huiping GuanHuiping Guan (9 patents)Bo PengBo Peng (6 patents)Dingwei YuDingwei Yu (5 patents)Stephanie K SpringerStephanie K Springer (3 patents)Audrey DaviesAudrey Davies (3 patents)Thomas Woodrow GeroThomas Woodrow Gero (3 patents)Ying KanYing Kan (2 patents)Ying KangYing Kang (2 patents)Xiaomei FengXiaomei Feng (1 patent)Susan AshwellSusan Ashwell (1 patent)Vibha OzaVibha Oza (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Astrazeneca Ab (3 from 1,500 patents)


3 patents:

1. 8486966 - 9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer

2. 8088784 - 4-(3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer

3. 7423061 - Substitute thiophenes and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…